Epigenetic immunomodulation by association of guadecitabine with ipilimumab (NIBIT-M4 Phase Ib trial, NCT02608437) has been shown to be safe and tolerable in advanced melanoma and to have significant
Background: Cancer is one of the deadliest diseases at present. Although effective screening and treatment can save lives to a certain extent, our knowledge of the disease is far from sufficient. KIF1
Additional file 1 : Table S1. Highly expressed serum miRNAs in patients with CRC compared to normal controls. Table S2. Different RNA extraction technologies utilized in this study. Table S3. Mean Cq
*Characteristics are compared between HIV serostatus groups with Wilcoxon rank-sum test for CTx and osteocalcin. †Multivariable analysis adjusted for age, gender, race, BMI, smoking, past 30 day alcoh